Jeffrey Wade
Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former President and Chief Financial Officer | $485,525 | $2,564,274 |
| 2023 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former President and Chief Financial Officer | $535,729 | $1,962,868 |
| 2022 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former President and Chief Financial Officer | $513,354 | $1,990,163 |
| 2021 | Lexicon Pharmaceuticals, Inc. (LXRX) | President and Chief Financial Officer | $476,319 | $1,651,683 |
| 2020 | Lexicon Pharmaceuticals, Inc. (LXRX) | President and Chief Financial Officer | $456,372 | $1,629,502 |
| 2019 | Lexicon Pharmaceuticals, Inc. (LXRX) | President and Chief Financial Officer | $444,431 | $1,614,323 |
| 2018 | Lexicon Pharmaceuticals, Inc. (LXRX) | Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer | $436,644 | $1,408,003 |
| 2017 | Lexicon Pharmaceuticals, Inc. (LXRX) | Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer | $427,038 | $1,214,435 |
Earnings-call appearances
-
Lexicon Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-02
Lexicon Pharmaceuticals, Inc. (LXRX)
-
Lexicon Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-08
Lexicon Pharmaceuticals, Inc. (LXRX)
-
Lexicon Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-03
Lexicon Pharmaceuticals, Inc. (LXRX)
-
Lexicon Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-05-05
Lexicon Pharmaceuticals, Inc. (LXRX)
-
Lexicon Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-07-30
Lexicon Pharmaceuticals, Inc. (LXRX)